Verification evidence is still being completed.
PDF / print export
Hemolens Diagnostics Sp. z o.o.
Wroclaw, Poland
- Verified lead
- Wojciech Jezewski
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Non-Invasive Cardiology Diagnostics, FFR-CT Blood-Flow Simulation, and Medical-Device Software
- Review cycle
- 24 April 2026
- Full address
- ul. Legnicka 48G, 54-202 Wroclaw, Poland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Hemolens Diagnostics About Us page naming Wojciech Jezewski as CEO.
- Editorial note
- Wroclaw cardiology diagnostics software developer with named CEO, Cardiolens FFR-CT Pro product, and EPO Patent Index 2024 Top 10 Polish innovators recognition.
Non-Invasive Cardiology Diagnostics, FFR-CT Blood-Flow Simulation, and Medical-Device Software
CE-marked medical device, EPO Patent Index 2024 Top 10 Polish Innovators, Public CEO disclosure
Wroclaw cardiology diagnostics software developer with named CEO, Cardiolens FFR-CT Pro product, and EPO Patent Index 2024 Top 10 Polish innovators recognition.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Wroclaw, Poland
Hemolens Diagnostics Sp. z o.o.
Non-Invasive Cardiology Diagnostics, FFR-CT Blood-Flow Simulation, and Medical-Device Software · Medical-device software delivery
Wroclaw cardiology diagnostics software developer with named CEO, Cardiolens FFR-CT Pro product, and EPO Patent Index 2024 Top 10 Polish innovators recognition.
- Lead
- Wojciech Jezewski (verified ↗)
- Address
- ul. Legnicka 48G, 54-202 Wroclaw, Poland (source ↗)
- Compliance
- CE-marked medical device
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- Medical-device software delivery
- Capabilities
- Cardiolens FFR-CT Pro Software · Coronary CT and Blood-Pressure Fusion · Blood-Flow Computational Simulation
- Founded
- 2017
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED APRIL 2026
Wojciech Jezewski
Chief Executive Officer
Full addressul. Legnicka 48G, 54-202 Wroclaw, Poland
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Physical site source
Teraz-Otwarte business directory listing Hemolens Diagnostics at Legnicka 48G in Wroclaw.
Open sourceMedical-device software delivery
Wroclaw, Poland. Non-Invasive Cardiology Diagnostics, FFR-CT Blood-Flow Simulation, and Medical-Device Software. Review completed on 24 Apr 2026.
Polish Health Ministry and EU MDR for medical-device oversight
CE-marked medical device, EPO Patent Index 2024 Top 10 Polish Innovators, Public CEO disclosure
Non-Invasive Cardiology Diagnostics, FFR-CT Blood-Flow Simulation, and Medical-Device Software
Wroclaw cardiology diagnostics software developer with named CEO, Cardiolens FFR-CT Pro product, and EPO Patent Index 2024 Top 10 Polish innovators recognition.
Editorial note
Hemolens Diagnostics is a Wroclaw medical-device software developer with a named CEO, recognition among Poland's Top 10 EPO Patent Index 2024 innovators, and a Cardiolens FFR-CT Pro product.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Cardiolens FFR-CT Pro Software
Coronary CT and Blood-Pressure Fusion
Blood-Flow Computational Simulation
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Cardiolens FFR-CT Pro product
Computational blood-flow simulation
Clinical validation workflows
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- VERIFIED ACTIVE 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Hemolens Diagnostics Sp. z o.o. located?
- Hemolens Diagnostics Sp. z o.o. operates from ul. Legnicka 48G, 54-202 Wroclaw, Poland, Wroclaw, Poland.
- Who runs Hemolens Diagnostics Sp. z o.o.?
- Hemolens Diagnostics Sp. z o.o. is led by Wojciech Jezewski, Chief Executive Officer. Verified 24 Apr 2026.
- What certifications does Hemolens Diagnostics Sp. z o.o. hold?
- Hemolens Diagnostics Sp. z o.o. is documented under CE-marked medical device.
- What does Hemolens Diagnostics Sp. z o.o. do?
- Wroclaw cardiology diagnostics software developer with named CEO, Cardiolens FFR-CT Pro product, and EPO Patent Index 2024 Top 10 Polish innovators recognition. Core capabilities: Cardiolens FFR-CT Pro Software, Coronary CT and Blood-Pressure Fusion, Blood-Flow Computational Simulation.
Editorial context
Related technical briefs
Briefs that name Wroclaw as a covered market or city.